Ignite Creation Date:
2024-05-05 @ 11:25 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00038610
Status:
COMPLETED
Last Update Posted:
2015-09-18
First Post:
2002-06-03
Brief Title:
Study of Hyper-CVAD Plus Imatinib Mesylate for Philadelphia-Positive Acute Lymphocytic Leukemia
Sponsor:
Organization:
MD Anderson Cancer Center